WallStreetZenWallStreetZen

NASDAQ: BBNX
Beta Bionics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Beta Bionics earnings were -$54.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest BBNX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$18.1M, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BBNX reported annual earnings of -$54.8M, with 24.2% growth.

BBNX earnings history

Current Revenue
$65.1M
Current Earnings
-$54.8M
Current Profit Margin
-84.1%

BBNX Return on Equity

Insufficient data to display

BBNX undefined

Current Company
-42.2%
Current Industry
8%
BBNX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BBNX announces earnings.

BBNX undefined

Current Company
-42.61%
Current Industry
9%

BBNX vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BBNX-$52.47M-$54.76MN/A-$8.60
SRDX$3.07M-$14.41MN/A-$1.02
TMCI-$39.72M-$55.74MN/A-$0.90
CTKB$10.03M-$6.02MN/A-$0.05
SENS-$68.70M-$78.62MN/A-$0.12
View Top Medical Device Stocks

Beta Bionics Earnings Reports & History FAQ

What were Beta Bionics's earnings last quarter?

Beta Bionics (NASDAQ: BBNX) reported Q4 2024 earnings per share (EPS) of -$2.74, up 17.72% year over year. Total BBNX earnings for the quarter were -$18.11 million. In the same quarter last year, Beta Bionics's earnings per share (EPS) was -$3.33.

If you're new to stock investing, here's how to buy Beta Bionics stock.

Is Beta Bionics profitable or losing money?

As of the last Beta Bionics earnings report, Beta Bionics is currently losing money. Beta Bionics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$54.76 million, a 24.17% increase year over year.

What was BBNX's earnings growth in the past year?

As of Beta Bionics's earnings date in Q2 2025, Beta Bionics's earnings has grown year over year. BBNX earnings in the past year totalled -$54.76 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.